InvestorsHub Logo
Followers 0
Posts 18
Boards Moderated 0
Alias Born 06/29/2022

Re: govprs post# 6928

Tuesday, 02/07/2023 9:38:37 AM

Tuesday, February 07, 2023 9:38:37 AM

Post# of 6939
While disappointed by the miss on Sesen's ability to execute an independent commercial launch of vicineum for bladder cancer, based on the facts and the financial market conditions last year, I think the transaction provides the best value for me and a good shot on goal with Carisma validated with the cash of the other pharma/investor players they attracted.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SESN News